Pharmacy Podcast Network

In this episode of TWIRx, we explore how pharmacy accounting has evolved from basic bookkeeping into a strategic business development tool powered by artificial intelligence, data analytics, and specialized accounting expertise. Pharmacy owner & PPN Podcast Host Dr. Adam Robinson and Titan Accounting’s team members Nicholas Caltabiano & Jordan Pridemore dig into what modern pharmacy owners must understand to stay financially healthy and competitive in today’s complex marketplace. Learn more by going to Titan's website: https://titanswork.com/home    Next, we talk with CEO & Founder of RxInsider, Gregory Cianfarani RPh, sharing the Colleges of Pharmacy Report 2025. RXinsider’s Market Intelligence Group produces weekly newsletters, market reports, and specialty INTEL Reports covering various segments of the pharmacy ecosystem—including an exclusive report on colleges of pharmacy.    Find the full report here:  https://ebook.rxinsider.com/flip-book/37174/2065397   Beyond the Ledger: How AI & Accounting Impacts Pharmacy Growth | TWIRx

In this episode, Dr. Ryan Paul Liabenow sits down with Kaleb Graves to explore the complex role of psychedelics in mental health treatment and addiction recovery. Together, they unpack the stigmas surrounding these substances. From the "cure all" claims to discrediting users who have become advocates. This conversation dives into harm reduction, spiritual framing, and the need for nuance in an increasingly polarized conversation about psychedelic medicine.

🎙️ Podcast Show Notes — McKesson ideaShare 2025 | Part Three: Frontline Voices of Pharmacy Innovation Presented by the Pharmacy Podcast Network | On-site Press Coverage In Part Three of our exclusive press coverage from McKesson ideaShare 2025 in Nashville, we spotlight some of the most influential voices shaping the future of independent pharmacy. This episode features five compelling interviews that explore digital health, public policy, clinical innovation, and pharmacy entrepreneurship. 💡 Featured Guests: U.S. Representative Diana Harshbarger  Tennessee's 1st Congressional District Mark Kinney - Independent Pharmacy Cooperative (IPC) Samantha Pomeroy Director of Pharmacy Services and Specialty Programs Independent Pharmacy Cooperative (IPC) Matthew Gilbert Eyecon RxSafe, LLC Marc Essensa CEO - Independent Pharmacy Cooperative (IPC) 🎧 Available now on all major podcast platforms. 🔗 https://mckessonideashare.com/  Sponsored by Independent Pharmacy Cooperative (IPC) https://www.ipcrx.com/   Stay tuned for Part Three — featuring more interviews with pharmacy leaders shaping the industry’s next chapter.

🎙️ Podcast Show Notes — McKesson ideaShare 2025 | Part Two: Frontline Voices of Pharmacy Innovation Presented by the Pharmacy Podcast Network | On-site Press Coverage In Part Two of our exclusive press coverage from McKesson ideaShare 2025 in Nashville, we spotlight some of the most influential voices shaping the future of independent pharmacy. This episode features five compelling interviews that explore digital health, public policy, clinical innovation, and pharmacy entrepreneurship. 💡 Featured Guests: Nancy Lyons, BSPharm, MBA, CDCES, Vice President & Chief Pharmacy Officer at Health Mart, McKesson Crystal Lennartz, PharmD, MBA Vice President, Pharmacy Performance at McKesson Corporation David Randolph owner of Dave's Pharmacy Matt Williams, Vice President, State Government Affairs at McKesson Marsha Millonig Rph., owner of Catalyst Enterprises, LLC Kris Rhea, Business Development at Pharmacy Marketplace Dr. Mark Fulton, PharmD with SoftWriters, Inc. Ollin Sykes, CPA, CITP, CMA, Pharmacy CPA Specialist, founder of Sykes & Company, P.A. 🎧 Available now on all major podcast platforms. 🔗 https://mckessonideashare.com/  Sponsored by Independent Pharmacy Cooperative (IPC) https://www.ipcrx.com/   Stay tuned for Part Three — featuring more interviews with pharmacy leaders shaping the industry’s next chapter.

This special episode of the NASP podcast features MedAdvisor leaders Megan Butterfield, Vice President of Network Solutions and Vinod Subramanian, Chief Operating and AI Officer in conversation with Shelia Arquette, President & CEO of NASP, as part of a collaborative spotlight for MedAdvisor Solutions' Beyond the Script podcast series. They discuss how AI, when applied thoughtfully, can help us not only meet the demands of patients’ increasingly intricate care journeys, but do so in a way that enhances the human experience, facilitating personalized engagement, real-time education, empathy and trust, while keeping what's special about specialty pharmacy. 

How can we prevent our older adults with prediabetes from developing diabetes?  Susan is a board certified health and wellness coach.  She is a certified with the CDC diabetes prevention program and owner of Weighting4You.  She will walk us through the use of continuous glucose monitors (CGMs) to assist with lowering HgbA1c, counseling tips for patients on GLP-1 RAs, and more.  I hope you enjoy our conversation.   The Geriatric Pharmacy Focus podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user’s own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Connect with Tamara here:  www.linkedin.com/in/tamara-ruggles-491882251 www.thedeprescribingclinic.com Connect with Susan here:linkedin.com/in/susanward https://weighting4you.com/

🎙️ Podcast Show Notes — McKesson ideaShare 2025 | Part One: Frontline Voices of Pharmacy Innovation Presented by the Pharmacy Podcast Network | On-site Press Coverage In Part One of our exclusive press coverage from McKesson ideaShare 2025 in Nashville, we spotlight some of the most influential voices shaping the future of independent pharmacy. This episode features five compelling interviews that explore digital health, public policy, clinical innovation, and pharmacy entrepreneurship. 💡 Featured Guests: Ashton Maaraba, President of IPC Digital Health, shares how Independent Pharmacy Cooperative is leading the charge in technology-driven patient care and empowering pharmacies with scalable digital tools. U.S. Representative Buddy Carter, a pharmacist and legislator from Georgia, offers a boots-on-the-ground policy perspective on PBM reform, scope expansion, and fighting for the future of community pharmacy. Greg Reybold, VP of Healthcare Policy at APCI, delivers key insights on how independent pharmacy advocacy is gaining momentum on Capitol Hill. Dr. Beshoy Gerges, CEO of St. Mary Pharmacy, discusses the intersection of clinical excellence and business strategy in high-performing community pharmacies. Christopher Darling, Pharmacy Owner Darling Apothecary Chuck Schneider from Lifecykel talks about functional wellness, medicinal mushrooms, and expanding pharmacy's role in holistic health. 🎧 Available now on all major podcast platforms. 🔗 https://mckessonideashare.com/  Sponsored by Independent Pharmacy Cooperative (IPC) https://www.ipcrx.com/   Stay tuned for Part Two — featuring more interviews with pharmacy leaders shaping the industry’s next chapter.

In this episode of Theory & Insights, we bring together two thought leaders at the intersection of healthcare innovation and pharmaceutical manufacturing — John Nosta, renowned AI and technology theorist and founder of NostaLab, and Stephen Beckman, CEO of YARAL Pharma, a rising force in U.S. generics. Together, they dive into the evolving impact of Artificial Intelligence (AI) and Large Language Models (LLMs) on pharmaceutical manufacturing. The discussion covers the promise and peril of AI in reshaping everything from R&D to regulatory pathways, as well as the ethics, economics, and operational shifts that could redefine the industry in the next decade. This is a must-listen for pharma execs, digital health strategists, and technology innovators looking to understand what’s next.

In this episode, YARAL Pharma CEO, Stephen Beckman joins clinical sports pharmacist Jessica Beal, PharmD. to discuss an important topic for athletes and active individuals – the role topical NSAID patches can play in acute pain management. Listeners can visit www.YARALPharma.com to learn more about the company and its products or connect on LinkedIn.    Diclofenac Epolamine Topical System 1.3%    Diclofenac Epolamine Topical System 1.3% is a nonsteroidal anti-inflammatory drug (NSAID) used for treating acute pain from minor strains, sprains, and bruises in adults and children aged 6 and older.     Serious side effects may include increased risk of cardiovascular and gastrointestinal (GI) events. NSAIDs can raise the risk of heart attack, stroke, gastrointestinal bleeding, ulceration, and perforation of the stomach and intestines, which can be fatal. The risk for serious cardiovascular events may occur early in treatment and may increase with duration of use. Elderly patients and those with a history of peptic ulcer disease or GI bleeding are at higher risk for serious GI events.    Do not use in patients who are allergic to diclofenac or any of its ingredients, or have a history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Do not use in the setting of coronary artery bypass graft surgery. Avoid use on broken skin. Discontinue immediately if signs of hypersensitivity occur.      Patients should be informed about the warning signs and symptoms of liver problems. Discontinue use if abnormal liver tests persist or worsen or if signs of liver disease develop. Avoid using Diclofenac Epolamine Topical System 1.3% in patients with severe heart failure unless the benefits are expected to outweigh the risks.    The most common side effects include itching, nausea, and headache. Patients should stop use and consult their doctor at the first sign of skin rash or other signs of sensitivity.    Patients should ask their doctor if Diclofenac Epolamine Topical System 1.3% is right for them. For more information and Full Prescribing Information including Boxed Warning and Important Safety Information, visit www.yaralpharma.com   Dr. Beal is not affiliated with YARAL Pharma. All views and opinions regarding pain management are solely her own and are not attributable to YARAL or the Pharmacy Podcast Network. 

Tune in to a multi-episode recap of the Retail Business Conference with returning special guest host Adam Robinson, Owner of Save-Rite Drugs in Lexington, Kentucky. Receive the highlights from Cardinal Health customers, employees, services and more at RBC 2025. This episode's topic is navigating Part B Biling for CGM Devices. This discussion will dive into the nuances that make Medicare billing a challenge for pharmacies and ways Cardinal may be able to help.